Stage II Melanoma
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lovastatin in Treating Patients At High Risk of Melanoma (NCT00462280) | National Cancer Institute (NCI) | 2007-05-01 |
Track Stage II Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.